BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 23, 2012
View Archived Issues
Roche presents novel antibodies targeting human chemokine CXCR5 receptor
Read More
Multiple-assay test shows promise to diagnose depression
Read More
Phase I trials assess Listeria-based vaccines in patients with cancer
Read More
Merck KGaA patents new P70S6K inhibitors
Read More
Novel tyrosine-protein kinase JAK inhibitors prepared by Rigel Pharmaceuticals
Read More
Novel diacylglycerol O-acyltransferase 1 inhibitors synthesized
Read More
Line extension for Zyprexa approved in Japan
Read More
UCB begins phase III Cimzia trial
Read More
Merck & Co. patents novel beta3-adrenoceptor agonists
Read More
Enanta out-licenses EDP-239 development
Read More
Washburn Therapeutics patents new wound-healing antibodies
Read More
New signaling pathway inhibitors developed in Sweden
Read More
New nanopore DNA strand sequencer is the size of a USB stick
Read More
NICE recommends earlier use of tocilizumab in RA
Read More
NICE confirms guidance on prolonged-release exenatide for type 2 diabetes
Read More
Enrollment begins in phase I/II trial of PET imaging agent
Read More
BMS gains additional indication approvals for two anticancer drugs
Read More
Mechanism and activity of ladarixin sodium explored
Read More
FDA advisory committee recommends approval of obesity therapy
Read More
Daiichi Sankyo and Terumo enter new vaccine collaboration
Read More
Onyx Pharmaceuticals reaches target enrollment in ASPIRE trial
Read More
Auxilium grants Actelion exclusive rights to Xiaflex in certain territories
Read More
FDA grants first approval for drug-eluting coronary stent use in AMI
Read More
NDS for insomnia therapy accepted for review by Health Canada
Read More
Collegium Pharmaceutical gives update on COL-003
Read More